Background Direct-acting oral anticoagulants (DOACs) have demonstrated superior efficacy
in preventing stroke and death compared with warfarin in patients with atrial fibrillation (AF) …

Background: Although widely used in clinical fields, real-world data on the role of warfarin
and non-vitamin K oral anticoagulants (NOACs) for the secondary prevention of …

In a systemic review of randomized controlled trials and cohort studies on oral
anticoagulation in atrial fibrillation (AF) patients published by Li et al1 in the latest issue of …

We would first like to thank Dr. Undas 1 for raising valuable questions about our recent study
2 that allow us to deeply discuss the administration of low-dose non-vitamin K antagonist …

In a systemic review of randomized controlled trials and cohort studies on oral
anticoagulation in atrial fibrillation (AF) patients published by Li et al 1 in the latest issue of …

We would first like to thank Dr. Undas 1 for raising valuable questions about our recent study
2 that allow us to deeply discuss the administration of low-dose non-vitamin K antagonist …